Emergent BioSolutions Inc...

NYSE: EBS · Real-Time Price · USD
8.85
0.03 (0.34%)
At close: Aug 15, 2025, 3:59 PM
8.82
-0.28%
After-hours: Aug 15, 2025, 07:40 PM EDT

Emergent BioSolutions Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-12M 68M -31.3M 114.8M -283.1M 9M -49.5M -263.4M -261.3M -183M -88M -75.7M -56.4M -3.7M 189.3M -32.7M 4.6M 69.7M
Depreciation & Amortization
23.5M 25.4M 26M 26.4M 29.4M 28.8M 30.5M 29.1M 32.9M 34.6M 35.6M 32.3M 44.5M 30.9M 29.2M 32.7M 33.2M 28.7M
Stock-Based Compensation
4.6M 1.5M 4.3M 2.3M 5.5M 5.9M 4M 4M 8.3M 6.8M 11.7M 11.2M 12.3M 9.9M 10.1M 10.4M 11.4M 10.5M
Other Working Capital
n/a -37.8M -9M 24.3M 195.9M -40.6M -8.9M -12.5M 1.5M -40M 80.4M -15.1M -6.3M -107.3M 43M -25.9M -8.8M -70M
Other Non-Cash Items
104.2M -6M 6.8M -62.7M 144.3M 123.8M 5.8M 218.6M 252.7M 2.8M 1.3M 12.5M 3.9M 2.1M -63.4M 91.2M 100K 5.6M
Deferred Income Tax
-13.9M 18.6M -400K 7.3M -200K -12.2M -5.2M 6.5M -1.8M -8.4M -42M 20.4M 700K 1.9M 46.3M 3.8M -1.5M -1.7M
Change in Working Capital
n/a -118.7M -85.3M 65.6M 205.9M -97.5M 46.5M 65.2M -145.2M -36.8M 174.2M -74.7M -20.6M -78.4M 117.5M -88.7M -77.5M -107.7M
Operating Cash Flow
106.4M -11.2M -79.9M 153.7M 47.5M -62.6M 32.1M 60M -114.4M -184M 92.8M -74M -15.6M -37.3M 329M 16.7M -29.7M 5.1M
Capital Expenditures
-2.9M -3.6M -1.7M -5.8M -4.6M -10.8M -11.4M -12.6M -12.5M -15.1M -23.6M -27.9M -32.1M -32.2M -46.7M -55.2M -67M -56.1M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -270.2M n/a 270.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
20.1M 63.1M 30.3M 117.8M n/a n/a 270.2M -6.3M 270.2M n/a -21.8M -243.7M n/a n/a n/a n/a n/a -88.6M
Investing Cash Flow
17.2M 59.5M 28.6M 112M -4.6M -10.8M -11.4M -18.9M 257.7M -15.1M -45.4M -271.6M -32.1M -32.2M -46.7M -55.2M -67M -56.1M
Debt Repayment
n/a n/a n/a -194M -51.4M 41.1M 4.1M -42.9M -496.2M -8.4M 351.5M 229.6M -8.4M -8.5M -8.4M -5.6M -5.7M -16.2M
Common Stock Repurchased
-6.9M n/a n/a n/a -200K -400K n/a -100K n/a -2.1M -200K -300K -24.4M -57.5M -106.3M -500K -800K -12.2M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
500K -400K 800K 4.4M 500K -400K 400K -100K 1.1M -2.1M 1.8M -300K 2.1M -4.5M 1M 600K 1.9M -6M
Financial Cash Flow
-6.4M -400K 500K -180.3M -50.9M 40.7M 4.7M -43M -486.9M -10.5M 353.1M 229.3M -30.7M -70.5M -110M -5M -3.8M -22.2M
Net Cash Flow
118.2M 47.2M -50.8M 85.4M -8M -32.7M 23.9M -90.5M -341.6M -212.4M 401.6M -117.3M -77.7M -140.3M 172.3M -43.7M -100.3M -73.5M
Free Cash Flow
103.5M -14.8M -81.6M 147.9M 42.9M -73.4M 20.7M 47.4M -126.9M -199.1M 69.2M -101.9M -47.7M -69.5M 282.3M -38.5M -96.7M -51M